MPO-ANCA-positive rapidly progressive glomerulonephritis after COVID-19 vaccination during treatment of plaque psoriasis with bimekizumab.

导出 LinkOut

翻译打印收藏纠错

第一作者： Takuya,Sugiura

第一单位： Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

作者： Takuya,Sugiura ^[1] ; Tomohito,Doke ^[2] ; Akihito,Tanaka ^[1] ; Yuka,Sato ^[1] ; Kayaho,Maeda ^[1] ; Kazuhiro,Furuhashi ^[1] ; Noritoshi,Kato ^[1] ; Tomoki,Kosugi ^[1] ; Shoichi,Maruyama ^[1]

作者单位： Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ^[1] Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan. tomorurira0220@gmail.com. ^[2]

关键词 Bimekizumab COVID19 vaccination IL17 antibody MPO-ANCA Psoriasis RPGN

主题词人类(Humans);男(雄)性(Male);老年人(Aged);肾小球肾炎(Glomerulonephritis);银屑病(Psoriasis);抗体, 抗中性白细胞胞质(Antibodies, Antineutrophil Cytoplasmic);过氧化物酶(Peroxidase);肾透析(Renal Dialysis);接种(Vaccination)

DOI 10.1007/s13730-024-00927-6

PMID 39297892

发布时间 2025-04-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

CEN case reports

2025年14卷2期

194-199页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

MPO-ANCA-positive rapidly progressive glomerulonephritis after COVID-19 vaccination during treatment of plaque psoriasis with bimekizumab.

CEN case reports

相似文献

CEN case reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

MPO-ANCA-positive rapidly progressive glomerulonephritis after COVID-19 vaccination during treatment of plaque psoriasis with bimekizumab.

CEN case reports

相似文献

CEN case reports

相关期刊

检索历史清除